跳至主要内容
临床试验/TCTR20240818003
TCTR20240818003招募中3 期

Effect of Weight Reduction Intervention versus Standard of Care among People Living with HIV Experiencing Significant Weight Gain from Dolutegravir-Based Regimens: A Randomized Controlled trial

Faculty of Medicine, CHIANG MAI University0 个研究点目标入组 58 人开始时间: 2024年8月18日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1 age more than 20 years
  • 2 weight gain more than 5% from baseline after receiving dolutegravir at least 6 months
  • 3 can give inform consent
  • 4 understand and use Thai language
  • 5 TMSE more than 24 points

排除标准

  • 1 steroid use
  • 3 underlying schizophrenia
  • 4 alcohol addiction
  • 5 can not walk more than 400 meter
  • 6 can not follow up
  • 7 plan to migrate in research period
  • 8 post gastrectomy for weight reduction
  • 9 on any medication for weight loss
  • 10 weight reduction by themselves more than 4.5 kg in 3 months or as baseline
  • 11 BMI less than 18.5 kg/m2
  • 12 weight more than 158 kg
  • 13 on hormonal therapy
  • 14 having any underlying disease that may obstruct trial

研究者

相似试验